Fig. 3From: Clinical features and prognosis of acute-on-chronic liver failure in patients with recompensated cirrhosisa-d, Comparison of 28-day, 90-day, 180-day, and 1-year cumulative survival rates of HBV-ACLF patients precipitated by hepatitis B virus reactivation and non-hepatitis B virus reactivationBack to article page